Vor Biopharma Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-17.4M | — |
| FY2020 | — | $-59.1M | $48.5M |
| FY2021 | — | $216.3M | $119.8M |
| FY2022 | — | $250.6M | $57.7M |
| FY2023 | — | $150.7M | $31.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-17.4M | — |
| FY2020 | — | $-59.1M | $48.5M |
| FY2021 | — | $216.3M | $119.8M |
| FY2022 | — | $250.6M | $57.7M |
| FY2023 | — | $150.7M | $31.4M |